Global Donor Egg Ivf (In-Vitro Fertilization) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Cycle Type;

Fresh Donor Egg Cycle and Frozen Donor Egg Cycle.

By End User;

Direct / Patient, Hospitals, and Fertility Clinics & IVF Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn157869444 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Donor Egg Ivf (In-Vitro Fertilization) Market (USD Million), 2021 - 2031

In the year 2024, the Global Donor Egg Ivf (In-Vitro Fertilization) Market was valued at USD 10,518.48 million. The size of this market is expected to increase to USD 18,860.79 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.

The global donor egg IVF (in-vitro fertilization) market has been experiencing significant growth, driven by advancements in reproductive technologies, increasing infertility rates, and evolving societal attitudes towards assisted reproductive treatments. Donor egg IVF, a process where eggs from a donor are fertilized with sperm in a laboratory setting and the resulting embryo is implanted into the recipient's uterus, has become a pivotal option for many individuals and couples struggling with infertility issues. This treatment offers a viable solution for those unable to conceive using their own eggs due to various factors such as advanced maternal age, genetic disorders, or previous unsuccessful IVF attempts. As awareness and acceptance of donor egg IVF continue to rise globally, the market for this procedure is expanding, fueled by both technological innovations and growing demand.

The increasing prevalence of infertility is a significant driver for the donor egg IVF market. Factors such as lifestyle changes, delayed childbearing, and rising incidences of conditions like polycystic ovary syndrome (PCOS) and endometriosis contribute to the growing need for assisted reproductive technologies. Moreover, societal shifts, including greater acceptance of single parenthood and same-sex couples seeking to start families, have broadened the market's reach. Technological advancements, such as improved egg retrieval techniques, enhanced embryo culture systems, and genetic screening, have significantly improved the success rates of donor egg IVF, making it a more attractive option for prospective parents. Additionally, the globalization of medical tourism has opened up new opportunities, with patients seeking affordable and high-quality fertility treatments abroad.

Despite the positive trends, the donor egg IVF market faces challenges, including ethical considerations, legal complexities, and high costs. Ethical debates around the commercialization of egg donation, the rights of donors and recipients, and the long-term implications for donor-conceived children remain areas of concern. Legal frameworks governing egg donation and IVF vary widely across countries, creating a complex landscape for international patients and clinics. Furthermore, the high costs associated with donor egg IVF procedures can be prohibitive for many, although insurance coverage and financial assistance programs are gradually improving access. As the market continues to evolve, addressing these challenges through regulatory harmonization, ethical guidelines, and cost-effective solutions will be crucial for sustained growth and broader accessibility.

In summary, the global donor egg IVF market is poised for continued expansion, driven by technological advancements, increasing infertility rates, and evolving social norms. While challenges persist, ongoing efforts to improve ethical standards, streamline legal processes, and make treatments more affordable are essential for the market's development. As more individuals and couples turn to donor egg IVF to achieve their dreams of parenthood, the industry is set to play a vital role in the future of reproductive medicine.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Cycle Type
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Donor Egg Ivf (In-Vitro Fertilization) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Infertility Rates

        2. Favorable Government Regulations

        3. Delayed Parenthood

        4. Growing Medical Tourism

      2. Restraints
        1. High Cost of Procedures

        2. Ethical Concerns

        3. Limited Availability of Donor Eggs

        4. Side Effects and Health Risks

      3. Opportunities
        1. Expanding Healthcare Infrastructure

        2. Rising Acceptance of IVF

        3. Collaborations and Partnerships

        4. Increased Funding and Research Initiatives

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Donor Egg Ivf (In-Vitro Fertilization) Market, By Cycle Type, 2021 - 2031 (USD Million)
      1. Fresh Donor Egg Cycle
      2. Frozen Donor Egg Cycle
    2. Global Donor Egg Ivf (In-Vitro Fertilization) Market, By End User, 2021 - 2031 (USD Million)
      1. Direct / Patient
      2. Hospitals
      3. Fertility Clinics & IVF Centers
    3. Global Donor Egg Ivf (In-Vitro Fertilization) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea ASEAN (Association of South East Asian Countries)
        6. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. California Cryobank
      2. Portfolio
      3. Growing Generations LLC
      4. Cryos International
      5. Fairfax EggBank
      6. Ovobank
      7. Center for Human Reproduction
      8. Generate Life Sciences
  7. Analyst Views
  8. Future Outlook of the Market